AR
Artiva Biotherapeutics, Inc. (ARTV) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$4.20
+1.20%
Mkt Cap $206.32M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | — | — | — | -$0.87 | -$0.84 | +3.45% |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.92 | -$0.88 | +4.35% |
| Q3 2025 Aug 6, 2025 | — | — | — | -$0.84 | -$0.87 | -3.57% |
| Q2 2025 May 8, 2025 | — | — | — | -$0.68 | -$0.83 | -22.06% |
| Q1 2025 Mar 25, 2025 | — | — | — | -$0.71 | -$0.66 | +7.04% |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.68 | -$0.92 | -35.29% |
| Q3 2024 Aug 29, 2024 | — | $251.00K | — | -$4.40 | -$22.00 | -400.00% |
| Q2 2024 Jun 30, 2024 | — | — | — | — | -$0.62 | — |
| Q4 2023 Dec 31, 2023 | — | $33.49M | — | — | -$0.30 | — |
| Q3 2023 Sep 30, 2023 | — | $26.66M | — | — | $1.20 | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.90 | — |
| Q1 2023 Mar 31, 2023 | — | $989.00K | — | — | -$0.95 | — |